Загрузка...

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Decreased major histocompatibility class II (MHCII) expression is associated with poor survival in diffuse large B-cell lymphoma (DLBCL). Immune-privileged site DLBCL (IP-DLBCL) patients reportedly have frequent large deletions at the MHCII locus whereas the mechanism of decreased expression in non-...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rimsza, Lisa M., Roberts, Robin A., Campo, Elias, Grogan, Thomas M., Bea, Silvia, Salaverria, Itziar, Zettl, Andreas, Rosenwald, Andreas, Ott, German, Muller-Hermelink, H. Konrad, Delabie, Jan, Fisher, Richard I., Unger, Joseph M., LeBlanc, Michael, Staudt, Louis M., Jaffe, Elaine S., Gascoyne, Randy D., Chan, Wing C., Weisenburger, Dennis D., Greiner, Timothy, Braziel, Rita M., Miller, Thomas P.
Формат: Artigo
Язык:Inglês
Опубликовано: © 2006 by The American Society of Hematology 2006
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895908/
https://ncbi.nlm.nih.gov/pubmed/16239429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-04-1510
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!